There are 2789 resources available
1362TiP - Capmatinib versus docetaxel in pretreated patients with MET exon 14 skipping-mutated locally advanced or metastatic NSCLC: The GeoMETry-III phase III study
Presenter: Pierre-Jean Souquet
Session: ePoster Display
1363TiP - A phase I/II study of TPX-0131, a novel oral ALK tyrosine kinase inhibitor, in patients with ALK+ advanced/metastatic NSCLC
Presenter: Ben Solomon
Session: ePoster Display
1364TiP - Phase II single-arm trial of safety, antitumor activity, and pharmacokinetics of tusamitamab ravtansine (SAR408701) plus ramucirumab in CEACAM5-positive, metastatic, non-squamous, non-small cell lung cancer progressing on platinum-based chemotherapy and immunotherapy
Presenter: Byoung Chul Cho
Session: ePoster Display
1423P - Genomic landscape in advanced gastric cancer from real-world data (RWD) of clinical genomic testing
Presenter: Hiroyuki Yamamoto
Session: ePoster Display
1424P - Landscape of germline mutations in Chinese patients with gastric cancer
Presenter: Yujian Zeng
Session: ePoster Display
1425P - Immune microenvironment and genomic alterations interpret heterogeneous response to immunotherapy in EBV-associated gastric carcinoma
Presenter: Zhi Peng
Session: ePoster Display
1426P - The utility of the prognostic index for practicing the continuum of care in advanced gastric cancer: The suitability assessment and modification of the JCOG prognostic index in real-world data
Presenter: Keitaro Shimozaki
Session: ePoster Display
1427P - Cancer/testis antigen expression landscape in gastroesophageal adenocarcinoma
Presenter: Sarbajit Mukherjee
Session: ePoster Display
1428P - Circulating nutritional biomarkers and their association with survival in patients with metastatic gastroesophageal cancer
Presenter: Hannah Christina Puhr
Session: ePoster Display